Alector Inc (ALEC)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

151 OYSTER POINT BLVD., SUITE 300 SOUTH SAN FRANCISCO, CA 94080

Alector, Inc. operates as a clinical stage biopharmaceutical company. The Company researches and develops novel therapeutics for the treatment of neurodegeneration and other brain disorders. Alector offers its services in the State of California.

Data as of 2021-02-20 14:23:04 -0500
Market Cap1.402 Billion Shares Outstanding79.243 Million Avg 30-day Volume565.902 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-7.34 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.25134 52-week High/Low34.89 / 9.12 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from ALEC instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 2 0 1 (0.06%) 0 (0.0%)
Funds Holding: 130 141 -7.8% 41 (2.47%) 50 (3.11%) -18.0%
13F shares: 45.669 Million 48.733 Million -6.29% 10.878 Million 14.865 Million -26.82%
% Ownership 57.6312 61.4978 -6.29% 13.7275 18.7592 -26.82%
New Positions: 16 35 -54.29% 4 17 -76.47%
Increased Positions 37 46 -19.57% 8 18 -55.56%
Closed Positions 21 30 -30.0% 12 15 -20.0%
Reduced Positions 47 35 34.29% 20 8 150.0%
Total Calls 255.391 Thousand 346.628 Thousand -26.32% 96.4 Thousand 101.2 Thousand -4.74%
Total Puts 207.143 Thousand 133.13 Thousand 55.59% 28.2 Thousand 31.9 Thousand -11.6%
PUT/CALL Ratio 0.81 0.38 113.16% 0.29 0.32 -9.38%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ALEC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ALEC BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

115.1 Thousand total shares from 5 transactions

Exercise Derivative Conversion (M)

115.1 Thousand total shares from 10 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PAUL ROBERT CHIEF MEDICAL OFFICER

  • Officer
213,719 2021-02-09 9

ROSENTHAL ARNON CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2020-10-01 1

YU CALVIN VICE PRESIDENT, FINANCE

  • Officer
0 2020-10-01 2

KING ROBERT CHIEF DEVELOPMENT OFFICER

  • Officer
0 2020-10-01 2

ONEY SABAH CHIEF BUSINESS OFFICER

  • Officer
0 2020-10-01 1

SULIMAN SHEHNAAZ PRESIDENT AND COO

  • Officer
0 2020-10-01 1

MCGUIRE TERRANCE

  • Director
  • 10% Owner
12,853,817 2020-06-23 2

POLARIS VENTURE MANAGEMENT CO. VI, L.L.C.

POLARIS VENTURE PARTNERS VI (AIV), L.P.

POLARIS VENTURE PARTNERS FOUNDERS' FUND VI, L.P.

POLARIS VENTURE PARTNERS VI, L.P.

PVP VI (AIV) FEEDER CORP. HOLDING PARTNERSHIP, L.P.

  • 10% Owner
12,853,817 2020-06-23 1

WEHNER DAVID M.

  • Director
0 2020-05-11 1

LAVIGNE LOUIS J JR

  • Director
0 2020-05-11 1

SCHELLER RICHARD H

  • Director
0 2020-05-11 1

GERNGROSS TILLMAN U.

  • Director
0 2020-05-11 1

YAFFE KRISTINE

  • Director
0 2020-05-11 1

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP IV LLC

  • 10% Owner
15,786,967 2020-04-14 4

HAMMOND PAULA

  • Director
0 2020-03-20 2

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP IV LLC

ORBIMED CAPITAL LLC

  • 10% Owner
8,716,344 2020-03-02 4

GORDON CARL L

  • Director
  • 10% Owner
0 2019-05-10 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

PAUL ROBERT - Officer CHIEF MEDICAL OFFICER

2021-02-11 17:08:17 -0500 2021-02-09 M 17,091 d 217,450 direct

PAUL ROBERT - Officer CHIEF MEDICAL OFFICER

2021-02-11 17:08:17 -0500 2021-02-09 M 17,091 $8.16 a 230,810 direct

PAUL ROBERT - Officer CHIEF MEDICAL OFFICER

2021-02-11 17:08:17 -0500 2021-02-09 S 19,175 $20.81 d 213,719 direct yes

PAUL ROBERT - Officer CHIEF MEDICAL OFFICER

2021-02-11 17:08:17 -0500 2021-02-09 M 2,084 d 60,417 direct

PAUL ROBERT - Officer CHIEF MEDICAL OFFICER

2021-02-11 17:08:17 -0500 2021-02-09 M 2,084 $10.14 a 232,894 direct

PAUL ROBERT - Officer CHIEF MEDICAL OFFICER

2021-01-27 18:53:42 -0500 2021-01-26 M 4,166 $10.14 a 241,027 direct

PAUL ROBERT - Officer CHIEF MEDICAL OFFICER

2021-01-27 18:53:42 -0500 2021-01-26 M 4,166 d 62,501 direct

PAUL ROBERT - Officer CHIEF MEDICAL OFFICER

2021-01-27 18:53:42 -0500 2021-01-26 M 23,142 $8.16 a 236,861 direct

PAUL ROBERT - Officer CHIEF MEDICAL OFFICER

2021-01-27 18:53:42 -0500 2021-01-26 M 23,142 d 234,541 direct

PAUL ROBERT - Officer CHIEF MEDICAL OFFICER

2021-01-27 18:53:42 -0500 2021-01-26 S 27,308 $18.00 d 213,719 direct yes

PAUL ROBERT - Officer CHIEF MEDICAL OFFICER

2021-01-27 18:53:42 -0500 2021-01-25 M 2,084 d 66,667 direct

PAUL ROBERT - Officer CHIEF MEDICAL OFFICER

2021-01-27 18:53:42 -0500 2021-01-25 M 2,084 $10.14 a 243,719 direct

PAUL ROBERT - Officer CHIEF MEDICAL OFFICER

2021-01-27 18:53:42 -0500 2021-01-25 M 27,916 d 257,683 direct

PAUL ROBERT - Officer CHIEF MEDICAL OFFICER

2021-01-27 18:53:42 -0500 2021-01-25 M 27,916 $8.16 a 241,635 direct

PAUL ROBERT - Officer CHIEF MEDICAL OFFICER

2021-01-27 18:53:42 -0500 2021-01-25 S 30,000 $18.01 d 213,719 direct yes

PAUL ROBERT - Officer CHIEF MEDICAL OFFICER

2021-01-21 18:46:12 -0500 2021-01-20 M 6,484 d 285,599 direct

PAUL ROBERT - Officer CHIEF MEDICAL OFFICER

2021-01-21 18:46:12 -0500 2021-01-20 S 8,567 $18.00 d 213,719 direct yes 9.4033 1.5069 9.4033 2 0.0 1

PAUL ROBERT - Officer CHIEF MEDICAL OFFICER

2021-01-21 18:46:12 -0500 2021-01-20 M 2,083 $10.14 a 222,286 direct 9.4033 1.5069 9.4033 2 0.0 1

PAUL ROBERT - Officer CHIEF MEDICAL OFFICER

2021-01-21 18:46:12 -0500 2021-01-20 M 2,083 d 68,751 direct

PAUL ROBERT - Officer CHIEF MEDICAL OFFICER

2021-01-21 18:46:12 -0500 2021-01-20 M 6,484 $8.16 a 220,203 direct 9.4033 1.5069 9.4033 2 0.0 1

PAUL ROBERT - Officer CHIEF MEDICAL OFFICER

2021-01-21 18:46:12 -0500 2021-01-19 M 27,917 $8.16 a 241,636 direct 9.4033 1.5069 9.4033 2 0.0 1

PAUL ROBERT - Officer CHIEF MEDICAL OFFICER

2021-01-21 18:46:12 -0500 2021-01-19 S 30,000 $18.12 d 213,719 direct yes 9.4033 1.5069 9.4033 2 0.0 1

PAUL ROBERT - Officer CHIEF MEDICAL OFFICER

2021-01-21 18:46:12 -0500 2021-01-19 M 2,083 d 70,834 direct

PAUL ROBERT - Officer CHIEF MEDICAL OFFICER

2021-01-21 18:46:12 -0500 2021-01-19 M 2,083 $10.14 a 243,719 direct 9.4033 1.5069 9.4033 2 0.0 1

PAUL ROBERT - Officer CHIEF MEDICAL OFFICER

2021-01-21 18:46:12 -0500 2021-01-19 M 27,917 d 292,083 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ALECTOR INC ALEC 2021-03-01 18:45:03 UTC -1.1881 1.2581 450000
ALECTOR INC ALEC 2021-03-01 18:15:03 UTC -1.1881 1.2581 450000
ALECTOR INC ALEC 2021-03-01 17:45:03 UTC -1.1881 1.2581 450000
ALECTOR INC ALEC 2021-03-01 17:15:03 UTC -1.1881 1.2581 450000
ALECTOR INC ALEC 2021-03-01 16:45:03 UTC -1.1881 1.2581 450000
ALECTOR INC ALEC 2021-03-01 16:15:02 UTC -1.1881 1.2581 450000
ALECTOR INC ALEC 2021-03-01 15:45:03 UTC -1.1881 1.2581 450000
ALECTOR INC ALEC 2021-03-01 15:15:02 UTC -1.1881 1.2581 450000
ALECTOR INC ALEC 2021-03-01 14:45:03 UTC -1.1881 1.2581 450000
ALECTOR INC ALEC 2021-03-01 14:15:03 UTC -1.1881 1.2581 450000
ALECTOR INC ALEC 2021-03-01 13:45:03 UTC -1.1881 1.2581 450000
ALECTOR INC ALEC 2021-03-01 13:15:03 UTC -1.1881 1.2581 450000
ALECTOR INC ALEC 2021-03-01 12:45:03 UTC -1.1881 1.2581 450000
ALECTOR INC ALEC 2021-02-26 22:15:02 UTC -1.1881 1.2581 900000
ALECTOR INC ALEC 2021-02-26 21:45:03 UTC -1.1881 1.2581 900000
ALECTOR INC ALEC 2021-02-26 21:15:02 UTC -1.1881 1.2581 900000
ALECTOR INC ALEC 2021-02-26 20:45:03 UTC -1.1881 1.2581 900000
ALECTOR INC ALEC 2021-02-26 20:15:03 UTC -1.1881 1.2581 900000
ALECTOR INC ALEC 2021-02-26 19:45:03 UTC -1.1881 1.2581 900000
ALECTOR INC ALEC 2021-02-26 19:15:03 UTC -1.1881 1.2581 900000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
INVESTMENT MANAGERS SERIES TRUST- 361 Domestic Long/Short Equity Fund ALEC -5568.0 shares, $-52394.88 2020-10-31 N-PORT
FundVantage Trust- Gotham Enhanced Index Plus Fund ALEC -101.0 shares, $-2437.13 2020-03-31 N-PORT
FundVantage Trust- Gotham Defensive Long Fund ALEC -32.0 shares, $-772.16 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund ALEC -128.0 shares, $-3088.64 2020-03-31 N-PORT

Elevate your investments